Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aztreonam Lysine for Inhalation in CF Patients with Mild Lung Disease
NCT00712166Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- May 2008
- Primary completion
- Jun 2009
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of aztreonam in cystic fibrosis (CF), sponsored by Gilead Sciences. Started May 2008; status: completed.
02
Drugs
aztreonam
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00712166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712166.